logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. University College London Hospitals NHS Foundation Trust

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

University College London Hospitals NHS Foundation Trust (UCLH), headquartered at 250 Euston Road, London NW1 2PG, is one of the largest and most prestigious National Health Service (NHS) foundation trusts in the United Kingdom. Closely partnered with University College London (UCL), the trust seamlessly translates world-class clinical research into advanced patient care, consistently ranking as a top acute teaching trust in England. UCLH operates multiple specialized facilities across central London, including its flagship University College Hospital, the National Hospital for Neurology and Neurosurgery, and the Royal National ENT and Eastman Dental Hospitals. It is highly regarded for its comprehensive acute services and expertise in major specialties such as oncology, cardiac diseases, women's health, neurosciences, and oral health.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Trial-derived.
176Total Trials
Source: Trial-derived.
47Recruiting Trials
Source: Trial-derived.
85Active Trials
Source: Trial-derived.
67Completed Trials
Source: Trial-derived.
345Unique Conditions
Source: Trial-derived.
184Unique Sponsors

Conditions

Source: Trial-derived. Multiple Myeloma (7)Source: Trial-derived. Lung Cancer (6)Source: Trial-derived. Neoplasms (5)Source: Trial-derived. Ovarian Cancer (5)Source: Trial-derived. Cancer (4)Source: Trial-derived. Bladder Cancer (3)Source: Trial-derived. Covid19 (3)Source: Trial-derived. COVID-19 (3)

Sponsors

Source: Trial-derived. University College, London (35)Source: Trial-derived. Hoffmann-La Roche (14)Source: Trial-derived. University College London Hospitals (10)Source: Trial-derived. Cancer Research UK (9)Source: Trial-derived. Janssen Research & Development, LLC (9)Source: Trial-derived. National Institute for Health Research, United Kingdom (8)Source: Trial-derived. Guy's and St Thomas' NHS Foundation Trust (7)Source: Trial-derived. Autolus Limited (6)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Brain imaging